NexPlasmaGen incorporated is a Canadian privately held company dedicated to providing noninvasive plasma technologies to the health care systems to fight cancer. We first focus on reducing breast cancer recurrence rates to improve patients' survival rates at difference local stages of the disease and to reduce hospital's and patient's costs associated with recurrence. Our plasma technology is safe, efficient, versatile and portable and has been proven in preclinical trials. Safety clinical trials are in preparation for 2023.

NexPlasmaGen

Org chart

Teams

Offices